Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, An Issue of Rheumatic Disease Clinics

By Kenneth J. Scalapino, MD and Charles R Thomas JR, MD

20% Offer applies to all Medicine reference and textbooks and/or PDF, VST, and ePub e-Books, as well as Clinics Review Articles - both individual issues and subscriptions. Offer is not valid on Journals, Institutional Video Series, HESI Products, Kindle or Nook e-books, select Nursing, Dentistry, and Veterinary vitalsource e-books and textbooks, Pageburst titles, ClinicalKey packages, mobile apps, medical clothing & accessories, previous purchases, bulk orders, clearance titles, or in combination with any other promotion. This Special Offer and FREE Shipping only valid for purchases by individual customers in the U.S., Mexico, Central and South America, and Caribbean at www.us.elsevierhealth.com. Current prices and offers are subject to change without notice. Enter promotional code 05984 at checkout. Offer ends on May 28, 2013.

☄ Disclaimer ☄ 20% Offer applies to all Medicine reference and textbooks and/or PDF, VST, and ePub e-Books, as well as Clinics Review Articles - both individual issues and subscriptions. Offer is not valid on Journals, Institutional Video Series, HESI Products, Kindle or Nook e-books, select Nursing, Dentistry, and Veterinary vitalsource e-books and textbooks, Pageburst titles, ClinicalKey packages, mobile apps, medical clothing & accessories, previous purchases, bulk orders, clearance titles, or in combination with any other promotion. This Special Offer and FREE Shipping only valid for purchases by individual customers in the U.S., Mexico, Central and South America, and Caribbean at www.us.elsevierhealth.com. Current prices and offers are subject to change without notice. Offer ends on May 28, 2013.
Enter promotional code 05984 at checkout.

$99.00

In Stock

This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.

View other titles in the “ The Clinics: Internal Medicine” Series

View all Rheumatology titles